Since 2020, I have spoken out about breast health due to my own experiences. My writing on this topic is featured below.
Navigating My Care in a Pandemic
Duke Center for Global Women's Health Technologies Blog, Oct. 21, 2020
Is this link broken/unresponsive? Try the Wayback Machine or contact me.
In May 2020, I had an excisional biopsy for a five-centimeter breast tumor. Although the tumor ended up being benign, the experience was an eye-opener; both for my knowledge about breast health and how care delivery can easily be disrupted. This essay describes that experience.
This essay was featured in GWHT's Summer of Storytelling Exhibit.
We Need More Awareness and Research on Benign Breast Conditions
Ms. Magazine, July 11, 2023
Is this link broken/unresponsive? Try the Wayback Machine or contact me.
A follow-up to Navigating My Care in a Pandemic, this essay describes what I've come to learn about benign breast disease in the years since my first tumor - and what researchers still don't know. This piece features interviews and data from the U.S. Medical Expenditures Panel Survey and National Ambulatory Medical Care Survey.
Nadia Bey's Breast Health Journey
Society for Women's Health Research Blog, March 26, 2025
Is this link broken/unresponsive? Try the Wayback Machine or contact me.
This blog describes my health journey and addresses the importance of research and eliminating cost-sharing for diagnostic breast imaging.
Hello! I am a graduate of Duke University (BA in Biology, BA in Global Health, minor in Computational Biology & Bioinformatics) and George Washington University (MPH in Health Policy) currently working in public health with additional experience in media.
At Duke, I was a University Scholar, Margolis Scholar and QuestBridge Scholar, and I graduated with distinction for my thesis on farmworker health. I attended GW on the Presidential Scholarship and completed my degree capstone on access to obstetric services in rural North Carolina.
I am driven by the belief that everyone deserves equal access to information and resources. I also enjoy projects where I am able to explore the whys and hows and gain familiarity with a topic; this has lent itself to my interests in research and reporting. My experience in different sectors is one of my greatest strengths. Being a reporter taught me how to ask questions and hunt down records, which was incredibly useful when I needed to develop a qualitative instrument or find evidence of a policy’s impact. I have also helped students and professionals with no journalism experience navigate working with journalism outlets.
Likewise, I can draw on the data analysis skills, ability to understand research studies, and policy advocacy training I gained through public health to help people understand the true impact of health decisions.
I also value creativity; I enjoy creative writing, making videos, and supporting the arts.
I have conducted research in academic settings as well as provided research for clients. Topic interests include health outcomes research, health care pricing, drug pricing, quality of care, access to services, oncology, and women's health.
My work in journalism and communications has included topics ranging from K-12 and higher education to science and health. I previously reviewed books for Affinity Magazine and now discuss books as a component of my YouTube channel, where I also talk about health and other trends. I also serve on the board of directors for the Duke Student Publishing Company, aka the Duke Chronicle, where I obtained much of my reporting training. In this role, I provide guidance to student reporters and help shape operational policy.
My own experience with benign breast disease influenced my involvement with Susan G. Komen as a volunteer Advocacy Ambassador. I communicate with state and federal legislators to advocate for policies that would promote breast cancer research and reduce patient costs. I have also written about breast health for publications and posted education and advocacy content on social media. I was featured on the Ambassador Spotlight in October 2025.
